Applying the basic knowledge about regulation of pigmentation towards development of strategies for cutaneous hypopigmentation

  • Abdel-Malek, Zalfa A. (Department of Dermatology Cincinnati University College of Medicine Ohio, USA)
  • Published : 2002.12.01

Abstract

The extensive variation in human cutaneous pigmentation is mainly due to differences in the rate of melanin synthesis by epidermal melanocytes, the relative amounts of eumelanin and pheomelanin synthesized, and the manner and rate of transfer of melanosomes from melanocytes to keratinocytes. Pigmentation is a complex trait that is regulated genetically and environmentally. One gene that has been receiving a lot of attention is the gene for the melanocortin 1 receptor The extensive polymorphism of this gene in human populations suggests its significance in the diversity of pigmentation. Exposure to solar ultraviolet radiation (UV) results in increased synthesis of a variety of growth factors, cytokines and hormones, and in modulation of their receptors in the epidermis. Knowledge about the regulation of pigmentation has led to strategies for clinical treatment of hyperpigmented skin lesions. Three main strategies are: 1) the use of chemicals that interfere with the melanin synthetic pathway, 2) the design of peptides or peptide-mimetics based on the structure of hormones that regulate eumelanin synthesis, and 3) the use of agents that reduce melanosome transfer from melanocytes to keratinocytes. All three strategies are expected to induce hypopigmentation, by inhibiting total melanin synthesis, eumelanin production, or the epidermal melanin unit, respectively.

인체피부의 색소침착에 있어서 다양한 차이는 주로 표피의 멜라닌생성 세포에 의한 멜라닌 합성 비율, 합성된 eumelanin과 pheomelanin의 상대적인 양과 melanocyte에서 keratinocyte로 melanosomes의 이동 속도와 그 방법에서 기인된다. 색소침착은 유전적, 환경적으로 조절되어지는 복합적 특성이다. 많은 관심이 집중되었던 하나의 유전자인 melanocortin 1 receptor 유전자가 있다. 인간집단에서 이 유전자의 다앙한 polymorphism은 색소침착의 다양성에 있어서 중요하다. 자외선(UV)에 대한 노출은 다양한 성장 요인, cytokines과 호르몬의 합성이 증가되고, 표피에서 그들 수용체들의 환경적응등이 나타난다. 색소침착 조절에 관한 정보는 과다색소 침착된 피부손상의 임상치료를 위한 전략들에서 이끌어 냈다. 주된 3개의 전략은 다음과 같다. 1) melanin 합성경로를 방해하는 화합물의 사용 2) eumelanin 합성을 조절하는 호르몬의 구조에서 기인된 peptides 또는 peptide-mimetics개발 3) melanocytes에서 keratinocytes로의 melanosome 이동을 감소시키는 물질의 개발. 이 모든 3가지의 전략은 각각 전체 멜라닌 합성, eumelanin 생성 또는 피부의 멜라닌 단위를 억제시킴으로 미백작용을 유도시킬 것으로 기대되어 진다.

Keywords

References

  1. Phenotypic Expression in Pigment Cells Photobiology of pigment cells Pathak,M.A.;Jimbow,K.;Fitzpatrick,T.;Seiji,M.(ed.)
  2. Pigment Cell Res. v.7 Proliferation and propagation of human melanocytes in vitro are affected by donor age and anatomical site Abdel-Malek,Z.A.;Swope,V.B.;Nordlund,J.J.;Medrano,E.E.
  3. J. Invest. Dermatol. v.95 The relationship between tyrosinase activity and skin color in human foreskins Iwata,M.;Corn,T.;Iwata,S.;Everett,M.A.;Fuller,B.B.
  4. J. Cell Sci. v.106 Contribution of melanogenic proteins to the heterogeneous pigmentation of human melanocytes Abdel-Malek,Z.;Swope,V.;Collins,C.;Boissy,R.;Zhao,H.;Nordlund,J.
  5. J. Invest. Dermatol. v.109 Melanogenesis in cultured melanocytes can be substantially influenced by L-tyrosine and L-cysteine Smit,N.P.M.;Van der Meulen H.;Koerten,H.K.;Kolb,R.M.;Mommaas,A.M.;Lentjes,EGWM;Pavel,S.
  6. Pigment Cell Res. v.8 Eumelanin and pheomelanin contents of human epidermis and cultured melanocytes Hunt,G.;Kyne,S.;Ito,S.;Wakamatsu,K.;Todd,C.;Thody,A.J.
  7. EMBO J. v.16 Modulation of murine melanocyte function in vitro by agouti signal protein Sakai,C.;Ollmann,M.;Kobayashi,T.;Adel-Malek,Z.;Muller,J.;Vieira,W.D.;Imokawa,G.;Barsh,G.S.;Hearing,V.J.
  8. J. Cell Sci. v.108 Modulation of melanogenic protein expression during the switch from eu- to pheomelanogenesis Kobayashi,T.;Vieira,W.D.;Potterf,B.;Sakai,C.;Imokawa,G.;Hearing,V.J.
  9. J. Invest. Dermatol. v.108 Agouti signaling protein inhibits melanogenesis and the response o human melanocytes to α-melanotropin Suzuki,I.;Tada,A.;Ollmann,M.M.;Barsh,G.S.;Im,S.;Lamoreux,M.L.;Hearing,V.J.;Nordlund,J.;Abdel-Malek,Z.A.
  10. Pigment Cell v.4 Ultrastructural comparison of pheo- and eu-melanogenesis in animals Jimbow,K.;Takeuchi,T.;KlausS.N.(ed.)
  11. Proceedings of the 10th International Pigment Cell Conference Biologic Basis of Pigmentaiton
  12. J. Invest. Dermatol. v.117 Keratinocytes play a role in regulating distribution patterns of recipient melanosomes in vitro Minwalla,L.;Zhao,Y.;Le Poole I.C.;Wickett,R.R.;Boissy,R.E.
  13. J. Invest. Dermatol. v.107 Ex vivo study of skin phototypes Bessou,S.;Surleve-Bazeille,J.E.;Pain,C.;Donatien,P.;Taieb,A.
  14. Biochim. Biophys. Acta v.1313 Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture : regulation by ultraviolet B Chakraborty,A.K.;Funasaka,Y.;Slominski,A.;Ermak,G.;Hwang,J.;Pawelek,J.M.;Ichihashi,M.
  15. J. Biol. Chem. v.267 Endothelins secreted from human keratinocytes are intrinsic mitogens for human melanocytes Imokawa,G.;Yada,Y.;Miyagishi,M.
  16. J. Cell Biol. v.107 Basic fibroblast growth factor from human keratinocytes is a nutural mitogen for melanocytes Halaban,R.;Langdon,R.;Birchall,N.;Cuono,C.;Baird,A.;Scott,G.;Moellmann,G.;McGuire,J.
  17. Proc. Natl. Acad. Sci. U.S.A. v.92 Mitogenic and melanogenic stimulation of normal human melanocytes by melanotropic peptides Abdel-Malek,Z.;Swope,V.B.;Suzuki,I.;Akcali,C.;Harriger,M.D.;Boyce,S.T.;Urabe,K.;Hearing,V.J.
  18. Cancer Res. v.58 Activation of the cAMP pathway by α-melanotropin mediates the response of human melanocytes to UVB light Im,S.;Moro,O.;Peng,F.;Medran,E.E.;Cornelius,J.;Babcock,G.;Nordlund,J.;Abdel-Malek,Z.
  19. J. Invest. Dermatol. v.96 Interleukins 1α and 6 and tumor necrosis factor-α are paracrine ingibitors of human melanocyte proliferation and melanogenesis Swope,V.B.;Abdel-Malek,Z.A.;Kassem,L.;Nordlund,J.J.
  20. J. Endocrinol. v.147 Agouti protein can act independently of melanocyte-stimulating hormone to inhibit melanogenesis Hunt,G.;Thody,A.J.
  21. Biochim. Biophys. Acta. v.1073 Mechanism of inhibition of melanogenesis by hydroquinone Palumbo,A.;d'Ischia,M.;Misurata,G.;Prota,G.
  22. J. Invest. Dermatol. v.62 Mechanism of depigmentation by hydroquinone Jimbow,K.;Obata,H.;Pathak,M.A.;Fitzpatrick,T.B.
  23. Carcinogenesis v.10 The role of GSH depletion and toxicity in hydroquinone-induced development of enzyme-altered foci. Stenius,U.;Warholm,M.;Rannug,A.;Walles,S.;Lundberg,I.;Hogberg,J.
  24. Br. J. Dermatol. v.133 Enhancement of the depigmenting effect of hydroquinone by cystamine and buthionine sulfoximine Bolognia,J.L.;Sodi,S.A.;Osber,M.P.;Pawelek,J.M.
  25. J. Pharmacol. Exp.Ther. v.276 Arbutin : Mechanism of its depigmenting action in human melanocyte culture Maeda,K.;Fukuda,M.
  26. Biochem Pharmacol v.57 Inhibitors of mammalian melanocyte tyrosinase : In vitro comparisons of alkyl esters of gentisic acid with other putative inhibitors Curto,E.V.;Kwong,C.;Hermersdorfer,H.;Glatt,H.;Santis,C.;Virador,V.;Hearing,V.J,Jr.;Dooley,T.P.
  27. Pigment Cell Res. v.1 Induction of melanogenesis suppression : cellular pharmacology and mode differential action Mishima,Y.;Hatta,S.;Ohyama,Y.;Inazu,M.
  28. J. Pharm Pharmacol. v.46 Kojic acid, a cosmetic skin whitening agent, is a slow-binding inhibitor of catecholase activity of tyrosinase Cabanes,J.;Chazarra,S.;Garcia-Carmona,F.
  29. JAMA v.266 Induction of skin tanning by the subcutaneous administration of a potent synthetic melanotropin Levine,N.;Sheftel,S.N.;Eytan,T.;Dorr,R.T.Hadley,M.E.;Weinrach,J.C.;Ertl,G.A.;Toth,K.;Hruby,V.J.
  30. Endocrinology v.137 Binding capacity and activation of the MCI receptors by melanotropic hormones correlate directly with their mitogenic and melanogenic effects on human melanocytes Suzuki,I.;Cone,R.;Im,S.;Nordlund,J.;Abdel-Malek,Z.
  31. J. Cell Sci. v.115 Human melanocortin1 receptor variants receptor function and melanocyte response to ultraviolet radiation Scott,M.C.;Wakamatsu,K.;Ito,S,;Kadekaro,A.L.;Kobayashi,N;Groden,J.;Kavanagh,R.;Takakuwa,T.;Virador,V.;Hearing,V.J.;Abdel-Malek,Z.A.
  32. J. Biol Chem. v.269 Discovery and structure-function analysis of alpha-melanocyte-stimulating hormone antagonists Jayawickreme,C.K.;Quillan,J.M.;Graminski,G.F.;Lerner,M.R.
  33. Peptides v.17 Characterization of a putative α-MSH antagonist 153N-6 at melanocortin receptor subtypes by radioligand binding Chhajlani,V.
  34. Peptides v.20 Synthesis of 153N-6 analogues and structure-function analysis at murine melanocortin-1 (MCI) receptors Sahm,U.G.;Olivier,G.W.J.;Pouton,C.W.
  35. Proc Natl Acad Sci. U.S.A. v.92 Combinatorial diffusion assay used to identify topically active melanocyte-stimulating hormone antagonists Quillan,J.M.;Jayawickreme,C.K.;Lerner,M.R.
  36. Proc Natl Acad Sci. U.S.A. v.91 Molecular structure and chromosomal mapping of the human homolog of the agouti gene Kwon,H.Y.;Bultman,S.J.;Loffler,C.;Chen,W.J.;Furdon,P.J.;Powell,J.G.;Usala,A.L.Wilkison,W.;Hansmann,I.;Woychik,R.P.
  37. Proc Natl Acad Sci. U.S.A. v.96 An agouti mutation lacking the basic domain induces yellow pigmentation but not obesity in transgenic mice Miltenberger,R.J.;Mynatt,R.L.;Bruce,B.D.;Wilkison,W.O.;Woychik,R.P.;Michaud,E.J.
  38. Exp Cell Res. v.259 Bioactive motifs of agouti signal protein Virador,V.M.;Santis,C.;Furumura,M.;Kalbacher,H.;Hearing,V.J.
  39. Science v.278 Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein Ollmann,M.M.;Wilson,B.D.;Yang,Y.K.;Kerns,J.A.;Chen,Y.;Gantz,I.;Barsh,G.S.
  40. Cell v.88 Targeted disruption of the melanocortin-4 receptor results in obesity in mice Huszar,D.;Lynch,C.A.;Fairchild-Huntress,V.;Dunmore,J.H.;Fang,Q.;Berkemeier,L.R.;Gu,W.;Kesterson,R.A.;Boston,B.A.;Cone,R.D.;Smith,F.J.;Campfield,L.A.;Burn,P.;Lee,F.
  41. J. Med. Chem. v.44 Novel agouti-related-protein-based melanocortin-1 receptor antagonist Thirumoorthy,R.;Holder,J.R.;Bauzo,R.M.;Richards,N.G.J.;Edison,A.S.;Haskell-Luevano,C.
  42. J. Muscle Res. Cell Mot. v.18 The predominant defect in dilute melanocytes is in melanosome distribution and not cell shape, supporting a role of myosin V in melanosome transport Wei,Q.;Wu,X.;Hammer,J.A.Ⅲ
  43. J. Invest Dermatol. v.116 Rab3a and SNARE proteins : potential regulators of melanosome movement Scott,G.;Zhao,Q.
  44. J. Invest Dermatol. v.115 Inhibition of melanosome transfer results in skin lightening Seiberg,M.;Panic,C.;Sharlow,E.;Costanzo,M.;Andrade-Gorden,P.;Eisinger,M.;Shapiro,S.S.
  45. J. Invest Dermatol. v.117 Protease-activated receptor 2, a receptor involved in melanosome transfer, is upregulated in human skin by ultraviolet irradiation Scott,G.;Deng,A.;Rodriguez-Burford,C.;Seigerg,M.;Han,R.;Babiarz,L.;Grizzle,W.;Bell,W.;Pentland,A.
  46. J. Invest Dermatol. v.116 An alternative approach to depigmentation by soybean extracts via inhibition of the PAR-2 pathway Paine,C.;Sharlow,E.;Liebel,F.;Eisinger,M.;Shapiro,S.;Seiberg,M.
  47. Biology on Normal and abnormal Melanocytes The photobiology of melanin pigmentation in human skin Panthak,M.A.;Hori,Y.;Szabo,G.;Fitzpatrick,T.B.;Kawamura,T.(ed.);Fitzpatrick,T.B.(ed.);Seiji,M.(ed.)